“Immune Biomarkers of Percutaneous Coronary Intervention Adverse Outcomes in Myocardial Infarction and Stable Angina Patients”. Asian Journal of Pharmaceutics (AJP), vol. 12, no. 03, Nov. 2018, https://doi.org/10.22377/ajp.v12i03.2653.